Data / Form D filings / Stipple Bio, Inc.
Stipple Bio, Inc.: Form D filings
Stipple Bio, Inc., a biotechnology company in Cambridge, MA, filed 3 Form D notices with the SEC between 2022 and 2026. The latest, on April 6, 2026, reports $65.1 million sold of a $100.2 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 238 Main Street, Cambridge, MA, 02142
- Phone
- (646) 248-0890
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1932776
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | New notice | $100,200,007 | $65,130,013 | $35,069,994 | 15 | Mar 31, 2026 | sec.gov |
| Dec 20, 2024 | New notice | $15,000,000 | $9,476,070 | $5,523,930 | 1 | Dec 20, 2024 | sec.gov |
| Jun 7, 2022 | New notice | $12,000,000 | $11,975,000 | $25,000 | 7 | May 31, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey Landau | Executive Officer, Director | |
| Vineeta Agarwala | Director | |
| Owen Hughes | Director | |
| Greg Verdine | Director | |
| Aaron Ring | Director | |
| Derek DiRocco | Director | |
| Thilo Schroeder | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Apr 6, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Stipple Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.